Citadel Advisors’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.5M Buy
711,257
+186,922
+36% +$2.77M ﹤0.01% 1330
2025
Q1
$9.4M Sell
524,335
-54,801
-9% -$982K ﹤0.01% 1290
2024
Q4
$10.1M Sell
579,136
-195,953
-25% -$3.41M ﹤0.01% 1318
2024
Q3
$10.8M Buy
775,089
+134,780
+21% +$1.89M ﹤0.01% 1206
2024
Q2
$5.26M Buy
640,309
+485,681
+314% +$3.99M ﹤0.01% 1650
2024
Q1
$1.19M Sell
154,628
-84,172
-35% -$649K ﹤0.01% 3007
2023
Q4
$2.15M Sell
238,800
-303,762
-56% -$2.73M ﹤0.01% 2334
2023
Q3
$4.85M Buy
542,562
+509,037
+1,518% +$4.55M ﹤0.01% 1640
2023
Q2
$515K Sell
33,525
-876,474
-96% -$13.5M ﹤0.01% 3616
2023
Q1
$20.5M Sell
909,999
-44,095
-5% -$992K ﹤0.01% 835
2022
Q4
$20.1M Sell
954,094
-145,596
-13% -$3.06M ﹤0.01% 871
2022
Q3
$27.1M Sell
1,099,690
-206,346
-16% -$5.08M 0.01% 661
2022
Q2
$31.6M Sell
1,306,036
-132,742
-9% -$3.22M 0.01% 592
2022
Q1
$37.1M Buy
1,438,778
+612,402
+74% +$15.8M 0.01% 569
2021
Q4
$25.7M Buy
826,376
+24,006
+3% +$745K 0.01% 793
2021
Q3
$19.5M Buy
802,370
+777,966
+3,188% +$18.9M ﹤0.01% 925
2021
Q2
$356K Buy
24,404
+5,201
+27% +$75.9K ﹤0.01% 5050
2021
Q1
$480K Sell
19,203
-945,325
-98% -$23.6M ﹤0.01% 4609
2020
Q4
$26.3M Buy
964,528
+336,048
+53% +$9.16M 0.01% 718
2020
Q3
$11.6M Buy
628,480
+275,585
+78% +$5.09M ﹤0.01% 1020
2020
Q2
$7.2M Buy
352,895
+238,339
+208% +$4.86M ﹤0.01% 1279
2020
Q1
$1.67M Buy
+114,556
New +$1.67M ﹤0.01% 2389
2019
Q4
Sell
-144,730
Closed -$1.68M 5134
2019
Q3
$1.68M Sell
144,730
-204,167
-59% -$2.37M ﹤0.01% 2520
2019
Q2
$7.01M Buy
348,897
+250,430
+254% +$5.03M ﹤0.01% 1417
2019
Q1
$2.23M Buy
98,467
+25,789
+35% +$584K ﹤0.01% 2236
2018
Q4
$1.65M Buy
+72,678
New +$1.65M ﹤0.01% 2378
2018
Q3
Sell
-50,851
Closed -$1.39M 4723
2018
Q2
$1.39M Sell
50,851
-22,518
-31% -$614K ﹤0.01% 2409
2018
Q1
$1.64M Sell
73,369
-284,914
-80% -$6.37M ﹤0.01% 2074
2017
Q4
$7.55M Sell
358,283
-52,554
-13% -$1.11M ﹤0.01% 1089
2017
Q3
$10.2M Sell
410,837
-196,935
-32% -$4.9M 0.01% 921
2017
Q2
$11.8M Sell
607,772
-201,119
-25% -$3.9M 0.01% 795
2017
Q1
$14.9M Buy
808,891
+535,720
+196% +$9.89M 0.01% 726
2016
Q4
$5.17M Buy
273,171
+204,270
+296% +$3.87M 0.01% 1041
2016
Q3
$1.54M Sell
68,901
-513,924
-88% -$11.5M ﹤0.01% 1695
2016
Q2
$10.4M Buy
582,825
+420,273
+259% +$7.48M 0.01% 710
2016
Q1
$2.22M Buy
162,552
+12,637
+8% +$173K ﹤0.01% 1374
2015
Q4
$2.89M Buy
149,915
+18,476
+14% +$356K ﹤0.01% 1396
2015
Q3
$2.66M Buy
131,439
+17,758
+16% +$360K ﹤0.01% 1579
2015
Q2
$3.77M Buy
113,681
+70,201
+161% +$2.33M ﹤0.01% 1402
2015
Q1
$1.04M Buy
43,480
+21,055
+94% +$505K ﹤0.01% 2181
2014
Q4
$274K Buy
22,425
+20,348
+980% +$249K ﹤0.01% 2906
2014
Q3
$19K Sell
2,077
-14,136
-87% -$129K ﹤0.01% 3338
2014
Q2
$190K Sell
16,213
-10,505
-39% -$123K ﹤0.01% 2829
2014
Q1
$568K Buy
+26,718
New +$568K ﹤0.01% 2239